Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review). | Int J Mol Med | 2023 | 37350412 | PubTator, text mining | PubMed |
| Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis. | Ann Rheum Dis | 2023 | 37344157 | PubTator, text mining | PubMed |
| Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma. | Mol Cancer Ther | 2023 | 37343247 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals maturation of transplanted stem cell-derived retinal pigment epithelial cells toward native state. | Proc Natl Acad Sci U S A | 2023 | 37339216 | PubTator, text mining | PubMed |
| JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37337631 | PubTator, text mining | PubMed |
| Regulon analysis identifies protective FXR and CREB5 in proximal tubules in early diabetic kidney disease. | BMC Nephrol | 2023 | 37337149 | PubTator, text mining | PubMed |
| miR-10a-3p modulates adiposity and suppresses adipose inflammation through TGF-β1/Smad3 signaling pathway. | Front Immunol | 2023 | 37334370 | PubTator, text mining | PubMed |
| Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells. | Environ Health Perspect | 2023 | 37307168 | PubTator, text mining | PubMed |
| Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review. | J Taibah Univ Med Sci | 2023 | 37305024 | PubTator, text mining | PubMed |
| CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets. | Cell Death Dis | 2023 | 37296107 | PubTator, text mining | PubMed |
| Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells. | Nat Biomed Eng | 2023 | 37291433 | PubTator, text mining | PubMed |
| Spinal meningiomas. | Neurooncol Adv | 2023 | 37287574 | PubTator, text mining | PubMed |
| Integrative profiling of gene expression and chromatin accessibility elucidates specific transcriptional networks in porcine neutrophils. | Front Genet | 2023 | 37287538 | PubTator, text mining | PubMed |
| Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis. | Nat Immunol | 2023 | 37277655 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
| Preparation of tanshinone IIA self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts. | Chin Herb Med | 2023 | 37265770 | PubTator, text mining | PubMed |
| Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma. | Front Genet | 2023 | 37252659 | PubTator, text mining | PubMed |
| macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. | Nat Commun | 2023 | 37244935 | PubTator, text mining | PubMed |
| Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival Outcome. | J Pers Med | 2023 | 37240940 | PubTator, text mining | PubMed |
| An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management. | J Pers Med | 2023 | 37240924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=17